註冊並分享邀請連結,可獲得影片播放與邀請獎勵。

Giannis Mountzios
@g_mountzios
#MedicalOncologist# MSc Transl Res Univ Paris Sud #LungCancer# biology, immunotherapy, clinical trials #LCSM# @myESMO faculty @iaslc live to give
加入 July 2015
1.4K 正在關注    3K 粉絲
Can T-cell engagers create a "tail of the curve" phenomenon in #SCLC#, in a way similar to ICIs? Apparently yes! Long-term Follow-up (22m) of the Dellphi-304 trial as published in @Annals_Oncology and reported in #ESMO2026# by @charlesrudin show 30% pts alive at 2 yrs with tarla compared to 15% with chemo. Sustained disease control for ≥52 weeks was observed in 24.4% versus 4.3%. Confirmatory results of prolonged tarla efficacy, giving hope to our patients @SclcSMASHERS @SCLCYIForum @LungCancerEu @YoungLungCancer @myESMO @IASLC @ASCO
顯示更多
0
2
60
15
轉發到社區